Illumina is an applied genomics technology company offering a range of innovative NGS platforms that deliver exceptional data quality and accuracy, at a massive scale. Illumina engaged Speaking of Science to create a suite of articles and case studies illustrating how its NGS sequencing systems and assays are revolutionizing research—from diagnosing disease in critically ill infants, to developing new treatments for cancer. We conducted a series of in-depth interviews with leading clinical and academic researchers to highlight how Illumina’s products have advanced breakthrough research in the fields of oncology, cardiovascular disease, genetic disease, infectious disease, neurology, reproductive health, and forensic science.   

PROJECT 

Content Creation
Copywriting
Digital Media
 

HOW WE HELPED